GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com
Patient Information Leaflet last updated on the eMC: 11/03/2010
PIL Zyban 150 mg prolonged release film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11/03/2010 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change due to user-testing of patient information
Updated on 14/05/2009 and displayed until 11/03/2010
Reasons for adding or updating:
  • Change to instructions about overdose
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to date of revision
Updated on 05/03/2009 and displayed until 14/05/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to side-effects
Updated on 07/11/2008 and displayed until 05/03/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
Updated on 27/10/2006 and displayed until 07/11/2008
Reasons for adding or updating:
  • Change to drug interactions
Updated on 14/02/2006 and displayed until 27/10/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 04/09/2003 and displayed until 14/02/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 11/06/2002 and displayed until 04/09/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 08/05/2002 and displayed until 11/06/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 13/07/2001 and displayed until 08/05/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 09/04/2001 and displayed until 13/07/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 07/12/2000 and displayed until 09/04/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   bupropion hydrochloride


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk